جست‌وجوی استاد و پژوهشگر

• Environmental Health Engineering
• Wastewater-Based Epidemiology
• Bioremediation
• +۷ مورد دیگر

Rolf Halden is a Professor and Center Director at Arizona State University, holding appointments in the School of Sustainable Engineering and the Built Environment, the Biodesign Center for Environmental Health Engineering, and the Global Futures Scientists and Scholars program. He is a leading expert in environmental health engineering, wastewater-based epidemiology, and bioremediation. Education: Ph.D. in Civil (Environmental) Engineering, University of Minnesota (1997) M.S. in Civil (Environmental) Engineering, University of Minnesota (1994) M.S. in Biology, Technical University of Braunschweig, Germany (1992) Postdoctoral Fellow, Environmental Science, Lawrence Livermore National Laboratory (1998) Research Focus: Halden’s research integrates environmental chemistry, public health, and sustainability to understand how anthropogenic chemicals affect ecological and human health. His lab uses advanced mass spectrometry (LC-MS/MS, MALDI-TOF) to track pollutants such as PPCPs, microplastics, pesticides, and dioxins across air, water, soil, and biological systems. He pioneered the use of wastewater treatment plants as public health observatories, enabling real-time tracking of disease, drug use, and environmental exposures. Scientific Awards & Recognition: Leadership Award, Arizona State University (2018) Rocky Mountain Emmy Award (2018) Leroy E. Burney Lecturer, Johns Hopkins School of Public Health (2011) ACS Expert Program Member (2014–present) NIEHS Superfund R01 Working Group National Leader (2012–2014) Labs & Teams: Halden is the Founding Director of the Biodesign Center for Environmental Health Engineering at ASU, where he leads a multidisciplinary team focused on environmental proteomics, bioremediation, and diagnostic tool development. He also co-leads the Human Health Observatory , a national wastewater monitoring network. Grants & Funding: Halden has secured major funding from NSF, NIH, EPA, DoD, and private industry. Notable projects include the development of in-situ groundwater monitoring devices, national wastewater surveillance of SARS-CoV-2, and studies on microplastics and neurodegenerative disease.

• Nuclear Magnetic Resonance (NMR)
• In vivo imaging
• MRI pulse sequence development
• +۷ مورد دیگر

Professor Guy Williams is a leading academic at the University of Cambridge with a focus on imaging science and clinical neurosciences, affiliated with Downing College and the Wolfson Brain Imaging Centre . Holding a PhD in Physics from his initial Natural Sciences degree, he specializes in nuclear magnetic resonance (NMR) and MRI techniques for brain imaging. Education: BA, PhD in Physics His research centers on non-invasive imaging of brain structure and function, particularly in traumatic brain injury (TBI) and dementia. His work involves developing novel MRI pulse sequences and advanced data analysis algorithms, including AI-based diagnostic tools. He leads studies on white matter integrity post-trauma, longitudinal dementia assessment, and applications of MRI in disorders of consciousness and addiction. Recent publications highlight collaborations in traumatic brain injury outcomes, AI-guided dementia prediction, and neuroimaging of post-COVID cognitive deficits. His team's work on ultra-high field laminar fMRI and distortion correction methods has advanced clinical neuroscience applications. Key techniques include diffusion tensor imaging (DTI), 7 Tesla MRI, and positron emission tomography (PET/MR). His research spans from basic NMR physics to clinical translation, with a strong emphasis on multi-site studies and real-world diagnostic implementation.

Vitaly Kheyfetsمشاهده پروفایل

دانشیار

• Pulmonary Arterial Hypertension
• Critical Care Medicine
• Pediatric Cardiology
• +۴ مورد دیگر

Vitaly Kheyfets, PhD, serves as Associate Professor in the Department of Pediatrics-Critical Care Medicine at the University of Colorado Anschutz Medical Campus School of Medicine, where he directs research at the intersection of pediatric critical care and cardiopulmonary pathophysiology with emphasis on pulmonary arterial hypertension (PAH). His primary research focuses on right ventricular adaptation to pulmonary hypertension, utilizing machine learning-driven multi-omics analysis to identify disease biomarkers and molecular networks. He pioneers computational fluid dynamics approaches for hemodynamic modeling in congenital heart conditions like Glenn physiology, while also investigating sleep oscillatory patterns as neurodegenerative biomarkers. His methodology integrates proteomics, spatial transcriptomics, and pressure waveform analysis to dissect vascular remodeling mechanisms. Publication trends reveal a strong emphasis on translating computational models into clinical applications for PAH prognostication, with recent work developing AI-cooperative diagnostic platforms and characterizing microvascular changes in the right ventricle. Cross-disciplinary collaborations span proteomics, imaging, and sleep neuroscience, demonstrating consistent innovation in both pulmonary hypertension and neurodegenerative disease biomarker discovery.

• Statistics
• Optimization
• Machine Learning
• +۳ مورد دیگر

Andrew Li is an Associate Professor of Operations Research at Carnegie Mellon University's Tepper School of Business since 2024, previously serving as Assistant Professor since 2018. His research bridges statistics, optimization, and machine learning with applications to healthcare operations and retail management. Current teaching: Optimization, Business Analytics Capstone, and Topics in Optimization and Statistics PhD from MIT's Operations Research Center (2018), BS in Operations Research/Applied Mathematics from Columbia University (2012) Research Focus: Dr. Li develops data-driven decision frameworks for complex systems. Key areas include: Experience-based learning models with fairness constraints (organ allocation) Anomaly detection in low-rank matrices (retail inventory accuracy) Nanoparticle-based diagnostic systems for CAD and Alzheimer's Nonstationary demand forecasting in supply chains Publication Trends: Recent work combines bandit algorithms with healthcare applications (split liver transplants, CAD detection) and retail operations (inventory accuracy). Theoretical contributions include regret-optimal policies and entrywise anomaly detection guarantees. Scientific Honors: INFORMS Nicholson Award (2018) INFORMS Pierskalla Award (2021) NSF CAREER Award (2023) Professional Leadership: Active in INFORMS and CMU committees including MBA Analytics Curriculum, Thompson Award, and ENAiBLE AI-driven retail collaborative co-founder since 2021.

• Cancer Genetics
• Prostate Cancer
• Genomic Evolution
• +۵ مورد دیگر

Colin Cooper is a Professor of Cancer Genetics at the Norwich Medical School, University of East Anglia. He is also a member of the Metabolic Health and Cancer Studies research groups. His work focuses on genomic evolution, tumor microbiome dynamics, and biomarker development for prostate cancer and musculoskeletal health. Cooper’s recent research explores the interplay between cancer genetics and microbial communities, emphasizing their role in prognosis and treatment outcomes. He investigates clonal evolution in tumors, mutational signatures, and non-invasive diagnostic tools like urinary extracellular vesicles. His collaborations span genomics, microbiology, and clinical applications. 2025: Causes of evolutionary divergence in prostate cancer (Genomics, Precision Medicine) 2024: Applications of urinary extracellular vesicles... (Biomarker Development, Liquid Biopsy) 2023: Caution regarding pan-cancer microbial structure (Methodological Considerations, Microbiome Analysis) In 2022, Cooper received the European Urology Oncology SoMe Award for his contributions. His work is frequently cited and has been featured in media outlets globally, highlighting his impact on cancer and aging research.

Jennifer Dyمشاهده پروفایل

استاد

• Machine Learning
• Computer Vision
• Explainable AI
• +۲ مورد دیگر

Jennifer Dy is a Distinguished Professor at Northeastern University with joint appointments in Electrical and Computer Engineering and Khoury College of Computer Sciences. As Director of AI Faculty at the Institute for Experiential AI, she leads research in machine learning, computer vision, and explainable AI. Her work spans biomedical applications (COPD phenotyping, neuroimaging) and fundamental algorithms (active learning, continual learning). She holds a PhD from Purdue University and is an AAAI Fellow. Research Focus: Dy develops methodologies for robust and interpretable machine learning, including techniques for model stability in continual learning, dependency-aware active learning, and axiomatic explanation frameworks. Her applied research advances diagnostic tools using Raman spectroscopy, CT imaging, and multi-omics biomarker discovery. Awards: Recognized with the NSF CAREER Award, Faculty Research Team Award, and AAAI Fellowship for contributions to unsupervised learning and medical AI. Publication Trends: Recent articles demonstrate strong cross-disciplinary integration, combining theoretical advances in explainability/robustness with applications in healthcare, wireless systems, and particle physics. Methodological themes include optimal transport theory, probabilistic modeling, and transformer architectures.

• Respiratory Physiotherapy
• Pulmonary Rehabilitation
• COPD
• +۷ مورد دیگر

Anne Holland is Professor of Physiotherapy and Head of Respiratory Research at Monash University and Alfred Health in Melbourne, Australia. She is an NHMRC Leadership Fellow (2021–2025) and a Chief Investigator for the NHMRC Centre of Research Excellence in Pulmonary Fibrosis and the NHMRC Centre of Research Excellence in Treatable Traits. Her research focuses on supportive therapies for chronic respiratory diseases, particularly COPD and pulmonary fibrosis, with a strong emphasis on pulmonary rehabilitation, telerehabilitation, and ambulatory oxygen therapy. Her research interests include: Respiratory physiotherapy Pulmonary rehabilitation (home-based and low-cost models) Access to care for chronic lung disease Telerehabilitation and digital health Symptom management in interstitial lung disease Exercise training and physical activity promotion Her recent publications focus on symptom management, digital self-management tools, treatable traits models, and clinical trials in pulmonary fibrosis and COPD. The body of work reflects a strong trend toward patient-centered, accessible, and evidence-based interventions that improve quality of life and clinical outcomes in chronic respiratory conditions. Her major scientific awards include: Society Medal, Thoracic Society of Australia and New Zealand (2021) European Respiratory Society Gold Medal for Allied Health Professionals (2022) NHMRC Investigator Fellow (Leadership 1) (2021) Fellow, Thoracic Society of Australia and New Zealand (2019) American Thoracic Society Pulmonary Rehabilitation Assembly Award (2016) Anne Holland supervises PhD students and is actively involved in advising and grant leadership. She is the Primary Chief Investigator on major trials such as the PERFORM trial and the TAPPET trial, and she leads a multinational ambulatory oxygen trial for fibrotic lung disease. Her work is supported by NHMRC and international collaborations. She is also President of the Thoracic Society of Australia and New Zealand, reflecting her leadership in the field. Anne leads the Holland Respiratory Care Research Group at Monash, which focuses on innovative models of care delivery, validation of remote monitoring tools, and improving patient self-management in chronic lung disease. The team collaborates widely across Australia and internationally, particularly in trials involving pulmonary rehabilitation and treatable traits.

Franz Lennard Ricklefsمشاهده پروفایل

استاد

• Neurosurgery
• Neuro-oncology
• Molecular Neurobiology
• +۵ مورد دیگر

Prof. Dr. med. Franz Lennard Ricklefs is a Senior Physician and Head of the Working Group at the Department of Neurosurgery, University of Hamburg Faculty of Medicine. He is a Medical Specialist in Neurosurgery with cross-disciplinary expertise in neuro-oncology, molecular pathology, and extracellular vesicle research. Affiliations: University Medical Center Hamburg-Eppendorf (UKE), European Liquid Biopsy Society (ELBS), International Consortium on Meningiomas (ICOM) Research Interests: His work focuses on neurosurgical oncology, particularly glioblastoma and meningioma pathobiology. He investigates DNA methylation patterns, extracellular vesicle biomarkers, and liquid biopsy implementation in clinical neuro-oncology. Additional interests include surgical outcomes for epilepsy and aneurysm management. Article Trends: Over the last decade, Dr. Ricklefs has published extensively on: Extracellular vesicle applications as liquid biopsy markers DNA methylation subclasses for glioblastoma and meningioma Multicenter surgical outcome benchmarking Immune evasion mechanisms in neuro-oncology Technological innovations in neurosurgical visualization Molecular characterization of rare CNS tumors Professional Contributions: He co-authored the MISEV2023 guidelines for extracellular vesicle studies and participates in international consensus reviews for meningioma classification. His collaborations span institutions across Europe and North America.

• Computational Biology
• Health Informatics
• Machine Learning
• +۳ مورد دیگر

Julia Camps is a postdoctoral research associate at the University of Oxford, Department of Computer Science. Her work bridges Computational Biology and Health Informatics, focusing on cardiac digital twin development for precision medicine applications. She specializes in combining data-driven and mechanistic approaches for in silico clinical trials, particularly through Purkinje network modeling and ECG-based calibration. Education: Informatics Engineer (2014) and Master's in Artificial Intelligence (2015-2017) from Universitat Politècnica de Catalunya PhD in Computer Science (2017-2021) at Oxford, completed within the Computational Cardiovascular Science research group under Prof Blanca Rodriguez Current role: postdoc in Prof Rodriguez's group since 2021, focusing on post-myocardial infarction disease progression Software development: open-source cardiac digital twin tools available on GitHub Her research interests center on creating patient-specific cardiac digital twins using multimodal clinical data. This work enables virtual therapy evaluation and in silico clinical trials through: Integration of statistical inference and machine learning techniques Development of Purkinje network models from clinical ECG data Electrophysiological and repolarization sequence modeling Gait detection algorithms for Parkinson's disease applications Recent publications (2024-2025) demonstrate trends in: GPU-accelerated cardiac electrophysiology simulations (MonoAlg3D) Topology-informed ECG electrode localization Sex-specific electromechanical cardiac modeling Multi-modal characterisation of diabetic cardiac deterioration Pro-arrhythmic risk assessment for stem cell therapies

Guojun Chenمشاهده پروفایل

استادیار

• Biomaterials
• Nanomedicine
• Tissue Engineering
• +۵ مورد دیگر

Guojun Chen is an Assistant Professor at the Department of Biomedical Engineering and a member of the Rosalind & Morris Goodman Cancer Institute (GCI) at McGill University . His research focuses on engineering intelligent biomaterials for precision medicine , with emphasis on non-viral genome editing , cold atmospheric plasma (CAP) therapy , and biomaterials-mediated immunotherapy . The lab operates in a multidisciplinary environment , integrating principles from materials science , chemistry , biology , and health sciences . Education : Ph.D. from University of Wisconsin-Madison (2017), Postdoc at UCLA (2020) Research Themes : Genome Editing Delivery : Designing non-viral vectors for efficient CRISPR/Cas9 delivery in vivo. CAP-mediated Immunotherapy : Developing portable cold plasma devices to synergize with immune checkpoint blockade and study CAP’s immunological mechanisms. Biomaterials-based Immunotherapy : Reprogramming tumor microenvironments using bioresponsive materials to enhance immune responses. Publication Trends : Recent work spans responsive nanomaterials , genomic editing systems , and plasma oncology , with a focus on cancer immunotherapy , diabetes diagnostics , and bioinspired medical devices . Scientific Awards : Canada Research Chair (2024, 2025) McGill's President's Prize for Emerging Researchers (2025) FRQS Chercheurs-boursiers (2022) Chinese Association for Biomaterials Young Investigator Award (2022) NSERC Discovery Grant (2021) Advising & Grants : Supervises 14 current graduate and undergraduate students. Secured $5M+ in funding from CIHR , NSERC , CCS , and CFI , including multi-institutional collaborations with Dr. Morag Park , Dr. Réjean Lapointe , and Dr. Ian Watson .

Emanuele Truccoمشاهده پروفایل

استاد

• Computer Vision
• Medical Image Analysis
• Retinal Image Analysis
• +۷ مورد دیگر

Professor Emanuele (Manuel) Trucco is the NRP Chair of Computational Vision in the Department of Computing, School of Science and Engineering, at the University of Dundee. He holds additional roles as an Honorary Clinical Researcher at NHS Tayside and formerly served as an Adjunct Professor at the Chinese Academy of Sciences from 2018 to 2021. He earned his MSc and PhD in Electronic Engineering from the University of Genoa, Italy, in 1984 and 1990, respectively. His research focuses on medical image and data analysis, particularly in retinal imaging, using machine and deep learning techniques. He is co-director of VAMPIRE, a major international initiative in retinal image analysis, which supports biomarker studies in cardiovascular disease, diabetes, dementia, and neurodegenerative disorders. His recent work includes AI-driven tools for predicting dementia from brain scans and cardiovascular risk from retinal images. The latest publications reflect strong trends in applying deep learning to retinal and brain imaging for early disease detection, with themes centered on AI in healthcare, precision medicine, and non-invasive diagnostics. FRSA (Fellow of the Royal Society of Arts) FIAPR (Fellow of the International Association for Pattern Recognition) Professor Trucco has led and co-led significant research projects funded by EPSRC, NIHR, and EU programs. He has supervised PhD students through industry-sponsored studentships (e.g., OPTOS, NIDEK, Toshiba) and collaborated with institutions such as the Universities of Edinburgh and Liverpool. His research is supported by extensive industrial partnerships including Canon Medical, Epipole plc, and NIDEK. He is a key member of the UK Biobank Eye and Vision Consortium and co-director of the VAMPIRE initiative, a collaborative effort between the Universities of Dundee and Edinburgh focused on retinal image analysis. His work also involves participation in major research networks such as the Academic Health Science Partnership in Tayside.

Tao Huanمشاهده پروفایل

دانشیار

• Metabolomics
• Exposomics
• Analytical Chemistry
• +۵ مورد دیگر

Tao Huan is an Associate Professor in the Department of Chemistry , University of British Columbia , and holds the Canada Research Chair in Metabolomics and Exposomics . His research focuses on advancing mass spectrometry (MS) for metabolomics , integrating bioinformatics to address challenges in cancer metabolism , disease biomarker discovery , and exposome characterization . Education: Ph.D. in Analytical Chemistry (University of Alberta, 2015), Postdoctoral Research Associate (The Scripps Research Institute, 2015-2018). Dr. Huan’s work emphasizes systems biology , combining metabolomics with genomics and proteomics to decode complex biological mechanisms. He has pioneered methods for chemical isotope labeling and multimodal data integration , enhancing metabolite identification and pathway analysis. His recent publications (2020-2019) highlight innovations in LC-MS/MS workflows , freeze-thaw sample stability , and applications in colorectal cancer and Alzheimer’s disease . Dr. Huan’s lab actively recruits students and postdocs in analytical chemistry, metabolomics, and bioinformatics. Awards: Fred Beamish Award (2025), President’s Award, Metabolomics Society (2025), UBC Killam Faculty Research Award (2024), Michael Smith Health Research BC Scholar Award (2023). He serves as a faculty member in UBC’s Graduate Program in Bioinformatics , Genome Science and Technology , and the Cluster for Microplastics, Health and Environment . Lab alumni include Ph.D. and M.Sc. students now in academia and industry.

Raymond T. Ngمشاهده پروفایل

استاد

• Data Mining
• Text Mining
• Health Informatics
• +۵ مورد دیگر

Raymond T. Ng is a Professor of Computer Science at the University of British Columbia (UBC) and serves as Director of the Data Science Institute . In addition, he is the part-time Chief Informatics Officer at the PROOF Centre of Excellence for the Prevention of Organ Failures located at St Paul’s Hospital. Since 2016 he has held the prestigious Canada Research Chair in Data Science and Analytics. Education B.Sc. (Hons.) Computer Science, University of British Columbia, 1986 M.Math. Computer Science, University of Waterloo, 1988 Ph.D. Computer Science, University of Maryland, College Park, 1992 Research Interests Professor Ng’s research lies at the intersection of data mining , text mining , health informatics , sensor analytics , and databases . Over the past decade he has focused on two major domains: Genomics & Biomarker Discovery: Developing multi-omics biomarker panels for heart, lung and kidney transplant rejection and COPD exacerbations using transcriptomics, proteomics and metabolomics data. Natural Language Processing: Mining and summarizing conversational text such as emails, blogs and meeting transcripts to generate structured metadata and actionable insights. Scientific Awards Canada Research Chair in Data Science and Analytics (2016-2026) Best Paper Award, ACM SIGMOD 2004 Best Paper Award, ACM SIGKDD 2001 Selected among Best Papers of VLDB ’99 & ’98 Governor General’s Gold Medal, UBC (1986) Research Funding & Leadership Since joining UBC in 1992, Professor Ng has continuously secured major peer-reviewed funding from NSERC, CIHR, Genome Canada, CFI, MITACS and industry partners (Google, IBM, SAP). He leads or co-leads several large-scale initiatives: HEARTBiT multi-marker blood test for cardiac transplant rejection (CIHR 2018-2021) MERIDIAN ocean acoustic data infrastructure (CFI 2018-2021) Pan-Canadian Early Detection of Lung Cancer (Terry Fox 2018-2021) Business Intelligence Network (NSERC 2009-2014) Multiple Genome Canada programs on biomarker translation (2004-2018) Laboratories & Teams Professor Ng directs the Data Science Institute and works closely with the Natural Language Processing Research Group . At the PROOF Centre he heads a multidisciplinary team of statisticians, computer scientists and clinicians advancing computational biomarker pipelines from discovery to clinical implementation.

• Neuro-oncology
• Neuropathology
• Glioblastoma
• +۳ مورد دیگر

Professor Patrick Harter is a faculty member at the Institute of Neuropathology, Ludwig Maximilian University of Munich (LMU), where he leads research in neuro-oncology and molecular diagnostics of CNS tumors. His work focuses on glioblastoma, meningioma, and brain metastasis, with emphasis on epigenetic mechanisms like DNA methylation and metabolic adaptations in the tumor microenvironment. Research interests span: Molecular classification of brain tumors using DNA methylation profiling Therapeutic targeting of BRAF/MEK and PI3K/Akt/mTOR pathways Role of hypoxia and metabolic plasticity in treatment resistance Liquid biopsy development for non-invasive tumor monitoring His recent publications demonstrate a strong trend toward integrating epigenetic, metabolic, and immunotherapeutic approaches. Articles frequently explore: Novel biomarkers for tumor grading and prognosis Mechanisms of therapy resistance in gliomas Impact of tumor microenvironment on metastasis

Wen Wangمشاهده پروفایل

استاد

• Biomedical Engineering
• Vascular Bioengineering
• Biomaterial Mechanics
• +۱۴ مورد دیگر

Prof Wen Wang is Professor of Biomedical Engineering and Vice-Principal and Executive Dean for Science and Engineering at Queen Mary University of London, affiliated with the School of Engineering and Materials Science and the Centre for Bioengineering. He is a Chartered Engineer and holds fellowships from the Institution of Mechanical Engineers (FIMechE), Higher Education Academy (FHEA), American Institute for Medical and Biological Engineering (FAIMBE), and the Royal Academy of Engineering (FREng), reflecting his leadership and technical excellence in engineering and biomedical sciences. His research focuses on vascular bioengineering , biomaterial mechanics , and cell biomechanics , with particular emphasis on the endothelial glycocalyx , vascular stem cells , and transmembrane transport . He employs advanced techniques such as AFM nano-indentation, confocal microscopy, and microfluidic platforms to study the mechanical properties, shear stress responses, and structural stability of biological systems. His work spans from fundamental biophysics to translational applications in drug delivery and cardiovascular disease. Prof Wang has led multidisciplinary research projects in the UK and through international collaborations with partners in the US, China, and Japan. His recent publications highlight sustained contributions to understanding microcapsule mechanics , extracellular vesicles , biofluid dynamics , and biomolecular sensing . His work integrates experimental and computational modeling, particularly in microcirculation and cellular transport phenomena. He has received notable scientific recognition through multiple prestigious fellowships and has published extensively in high-impact journals including Nature Communications , Journal of Controlled Release , Biosensors and Bioelectronics , and Journal of Fluid Mechanics . His research demonstrates a strong trajectory in both fundamental discovery and applied biomedical innovation. Prof Wang actively supervises research and collaborates with clinical and engineering partners at Queen Mary and King's College London. His leadership in the School of Engineering and Materials Science underscores his role in shaping academic strategy and research excellence in science and engineering at Queen Mary University of London.